The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and PRKN/PINK1-mediated Parkinson’s disease – a large-scale targeted metabolomics study
Preprint in medRxiv (March 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Preprint in medRxiv (March 2024)
Article in Antioxidants (February 2024)
Article in Chinese Chemical Letters (February 2024)